Medicines Co (MDCO) Tops Q1 EPS by 13c

April 25, 2012 8:37 AM EDT
Medicines Co (NASDAQ: MDCO) reported Q1 EPS of $0.27, $0.13 better than the analyst estimate of $0.14. Revenue for the quarter came in at $126.6 million versus the consensus estimate of $123.99 million.

For earnings history and earnings-related data on Medicines Co (MDCO) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings